Evidence map›Paper›PMID 35974956›Full record

ArticleNMC case report journal2022

Genetic Alteration May Proceed with a Histological Change in Glioblastoma: A Report from Initially Diagnosed as Nontumor Lesion Cases.

Hayato Takeuchi, Yoshinobu Takahashi, Seisuke Tanigawa, Takanari Okamoto, Yoshinori Kodama, Yukiko Shishido-Hara, Ema Yoshioka, Tomoko Shofuda, Yonehiro Kanemura, Eiichi Konishi and 1 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in NMC case report journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Hayato TakeuchiDepartment of Neurosurgery, Kyoto Prefectural University Graduate School of Medical Science, Kyoto, Kyoto, Japan.
Yoshinobu TakahashiDepartment of Neurosurgery, Kyoto Prefectural University Graduate School of Medical Science, Kyoto, Kyoto, Japan.
Seisuke TanigawaDepartment of Neurosurgery, Kyoto Prefectural University Graduate School of Medical Science, Kyoto, Kyoto, Japan.
Takanari OkamotoDepartment of Neurosurgery, Kyoto Prefectural University Graduate School of Medical Science, Kyoto, Kyoto, Japan.
Yoshinori KodamaDivision of Pathology Network, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Yukiko Shishido-HaraDepartment of Pathology and Applied Neurobiology, Kyoto Prefectural University Graduate School of Medical Science, Kyoto, Kyoto, Japan.
Ema YoshiokaDepartment of Biomedical Research and Innovation, Institute for Clinical Research, National Hospital Organization Osaka National Hospital, Osaka, Osaka, Japan.
Tomoko ShofudaDepartment of Biomedical Research and Innovation, Institute for Clinical Research, National Hospital Organization Osaka National Hospital, Osaka, Osaka, Japan.
Yonehiro KanemuraDepartment of Biomedical Research and Innovation, Institute for Clinical Research, National Hospital Organization Osaka National Hospital, Osaka, Osaka, Japan.
Eiichi KonishiDepartment of Pathology, Kyoto Prefectural University Graduate School of Medical Science, Kyoto, Kyoto, Japan.
Naoya HashimotoDepartment of Neurosurgery, Kyoto Prefectural University Graduate School of Medical Science, Kyoto, Kyoto, Japan.
Kyoto Prefectural University · JPOsaka National Hospital · JPKobe University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite recent signs of progress in diagnostic radiology, it is quite rare that a glioblastoma (GBM) is detected asymptomatically. We describe two patients with asymptomatic nonenhancing GBMs that were not diagnosed with neoplasia at first. The patients had brain scans as medical checkups, and incidentally lesions were detected. In both cases, surgical specimens histopathologically showed no evidence of neoplasia, whereas molecular genetic findings were isocitrate dehydrogenase (IDH)-wildtype, O

Indexed as

asymptomatic glioblastomaIDH-wildtypenonenhancing glioblastomaTERT mutated

Identifiers

PMID35974956
PMCPMC9339260
OpenAlexW4284879919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.